Generate Biomedicines, Inc. Common Stock (GENB NASDAQ) stock market data APIs
$15.2454
0.07(0.5%)
as of September 10, 2026
Try our APIs with
free plan!
Generate Biomedicines, Inc. Common Stock Financial Data Overview
Price chart is built with
Anychart
Generate Biomedicines, Inc., engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics in the United States. It uses protein-based modalities for drug development. Its product includes GB-0895, is an investigational long-acting anti-TSLP monoclonal antibody in development for severe asthma that is intended to be dosed every six months; GB-4362, an MMAE payload neutralizer monoclonal antibody; GB-5267, A MUC16 CAR-T Cell therapy. In additional, it develops Generate Platform, designed to be a therapeutic area and protein modality agnostic system integrating computational innovation with scalable biohardware to address therapeutic challenges beyond the reach of traditional technologies. Generate Biomedicines, Inc. was formerly known as Generate Biologics, Inc. and changed its name to Generate Biomedicines, Inc. in February 2020. The company was incorporated in 2018 and is based in Somerville, Massachusetts.
Prev. Close
15.2454
Open
15.3063
High
16.1195
Low
15.0115
52 wk Range
11-22.6699
Market Cap
1 992 M
Shares Outstanding
128 M
Revenue
26 483 K
EPS
-0.52
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Generate Biomedicines, Inc. Common Stock (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Generate Biomedicines, Inc. Common Stock data using free add-ons & libraries
Get Generate Biomedicines, Inc. Common Stock Fundamental Data
Generate Biomedicines, Inc. Common Stock Fundamental data includes:
- Net Revenue: 26 483 K
- EBITDA: -249 548 000
- Earnings Per Share: -2
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Generate Biomedicines, Inc. Common Stock Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2026-08-06
- EPS/Forecast: -0.48
Get Generate Biomedicines, Inc. Common Stock End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Generate Biomedicines, Inc. Common Stock News
New
AI Could Eventually Crack Cancer and Drug Discovery, Says Arm CEO — But This Is What’s Holding It Back
Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Arm Holdings PLC CEO Rene Haas said artificial intelligence could help find a cure for cancer with...
EXCLUSIVE: Nvidia GPUs Are Essential—But They Won't Decide Who Wins AI Drug Discovery, Generate CTO Says
Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Nvidia Corp's GPUs have become the backbone of artificial intelligence, but they won't be enough t...
Cathie Wood Sends a $20 Million Signal on Broadcom Stock
This article first appeared on GuruFocus. Cathie Wood's ARK Invest adjusted several technology holdings on Wednesday, adding to Broadcom while trimming its position in Advanced Micro Devices. ARK pu...
Generate Biomedicines surges again, rises 12% to new high
[Wall street.] bodrumsurf/iStock via Getty Images Shares of Generate Biomedicines (GENB [https://seekingalpha.com/symbol/GENB]), an AI-driven drug discovery company, advanced about 12% today. Shares ...
Get Generate Biomedicines, Inc. Common Stock fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
